Dimitris Voliotis

ZNTL

Dimitris Voliotis serves as SVP, Clinical Development at Zentalis Pharmaceuticals, Inc. (ZNTL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

2 trades

$1.87M

Net Position

Net Seller

$1.87M

Companies Traded

ZNTL

Active Period

Jan 2022 – Feb 2022

2 total trades

Most Recent

Sell ZNTL

Feb 14, 2022 · $30.2K

Dimitris Voliotis's Insider Trading at Zentalis Pharmaceuticals, Inc. (ZNTL)

Buys

0 · $0.00

Sells

2 · $1.87M

Total Shares Bought

Total Shares Sold

30,601

ZNTL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 14, 2022	Sell	601	$50.23	$30.2K	16,045
Jan 20, 2022	Sell	30,000	$61.36	$1.84M	12,841

Related Insiders

Ingmar Bruns

officer: Chief Medical Officer

ZNTLSell · Feb 10, 2026

EASTLAND JULIA MARIE

director, officer: CEO & President

ZNTLSell · Feb 10, 2026

Vultaggio Vincent

PAO and PFO

ZNTLSell · Feb 10, 2026

WALTERS GROUP

10% Owner

ZNTLBuy · Dec 31, 2025

Scott Dunseth Myers

Director

ZNTLBuy · Apr 30, 2025

Explore More Insider Trading Data

ZNTL Insider Trading Activity

View all insider trades at Zentalis Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity